Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fendrix vs Engerix B Immune Response in Healthy Males
NCT02032160Completed
- Sponsor
- University of Surrey
- Start
- May 2014
- Primary completion
- Feb 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Randomised trial of hepatitis B vaccine recombinant and Hepatitis B vaccine in hepatitis B (HBV), sponsored by University of Surrey. Primary endpoint: Change from pre-immunisation baseline values in global gene expression measured on whole blood samples at Day 168. Started May 2014; status: completed.
02
Drugs
hepatitis B vaccine recombinantHepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT02032160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02032160.